✦ LIBER ✦

Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancer

✍ Scribed by Spencer W Redding; Marta C Dahiya; William R Kirkpatrick; Brent J Coco; Thomas F Patterson; Annette W Fothergill; Michael G Rinaldi; Charles R Thomas Jr

Book ID: 116940429
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 244 KB
Volume: 97
Category: Article
ISSN: 1528-395X
DOI: 10.1016/j.tripleo.2003.09.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Candida glabrata is an emerging cause of

Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancer

✍ M.C Dahiya; S.W Redding; R.S Dahiya; T.Y Eng; W.R Kirkpatrick; B.J Coco; L Sadko 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 20 KB

Oral candidiasis in patients receiving r

Oral candidiasis in patients receiving radiation therapy for head and neck cancer

✍ Zeyi Deng; Asanori Kiyuna; Masahiro Hasegawa; Isamu Nakasone; Atsushi Hosokawa; 📂 Article 📅 2010 🏛 SAGE Publications 🌐 English ⚖ 594 KB

Oropharyngeal candidiasis caused by non-

Oropharyngeal candidiasis caused by non-albicans yeast in patients receiving external beam radiotherapy for head-and-neck cancer

✍ Marta C Dahiya; Spencer W Redding; Rajiv S Dahiya; Tony Y Eng; William R Kirkpat 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Risk factors for oropharyngeal candidias

Risk factors for oropharyngeal candidiasis in patients who receive radiation therapy for malignant conditions of the head and neck

✍ Joel B. Epstein; Marshall M. Freilich; Nhu D. Le 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 662 KB

Clinical determinants of weight loss in

Clinical determinants of weight loss in patients receiving radiation and chemoirradiation for head and neck cancer: A prospective longitudinal view

✍ Catherine Kubrak; Kärin Olson; Naresh Jha; Rufus Scrimger; Matthew Parliament; L 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB

Phase II Multicenter Trial of Caphosol f

Phase II Multicenter Trial of Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer

✍ N.G. Rao; A. Trotti; J. Kim; M. Schell; X. Zhao; R. Amdur; D. Brizel; M. Chamber 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 39 KB